.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
McKesson
Deloitte
US Department of Justice
Baxter
Queensland Health
Mallinckrodt
Cipla
Merck
Johnson and Johnson

Generated: July 23, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide; moexipril hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; moexipril hydrochloride and what is the scope of hydrochlorothiazide; moexipril hydrochloride patent protection?

Hydrochlorothiazide; moexipril hydrochloride
is the generic ingredient in two branded drugs marketed by Glenmark Pharms, Ucb Inc, Heritage Pharms Inc, Teva, and Chartwell Rx, and is included in five NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; moexipril hydrochloride. Four suppliers are listed for this compound.

Summary for Generic Name: hydrochlorothiazide; moexipril hydrochloride

Tradenames:2
Patents:1
Applicants:5
NDAs:5
Drug Master File Entries: see list31
Suppliers / Packagers: see list4
Clinical Trials: see list2,553
Drug Prices:see low prices
DailyMed Link:hydrochlorothiazide; moexipril hydrochloride at DailyMed

Pharmacology for Ingredient: hydrochlorothiazide; moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL090096-001Sep 25, 2008DISCNNoNo► Subscribe► Subscribe
Heritage Pharms Inc
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL202150-001Mar 7, 2014ABRXNoNo► Subscribe► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-003Feb 14, 2002DISCNNoNo► Subscribe► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-001Jun 27, 1997DISCNNoNo► Subscribe► Subscribe
Chartwell Rx
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL090096-003Sep 25, 2008DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: hydrochlorothiazide; moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-002Jun 27, 19974,743,450► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-001Jun 27, 19974,344,949► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-003Feb 14, 20024,743,450► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-002Jun 27, 19974,344,949► Subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-001Jun 27, 19974,743,450► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Covington
Cantor Fitzgerald
Argus Health
McKinsey
Colorcon
Daiichi Sankyo
Medtronic
Citi
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot